Literature DB >> 33446559

Cryo-EM structure of the B cell co-receptor CD19 bound to the tetraspanin CD81.

Katherine J Susa1, Shaun Rawson1, Andrew C Kruse2, Stephen C Blacklow2,3.   

Abstract

Signaling through the CD19-CD81 co-receptor complex, in combination with the B cell receptor, is a critical determinant of B cell development and activation. It is unknown how CD81 engages CD19 to enable co-receptor function. Here, we report a 3.8-angstrom structure of the CD19-CD81 complex bound to a therapeutic antigen-binding fragment, determined by cryo-electron microscopy (cryo-EM). The structure includes both the extracellular domains and the transmembrane helices of the complex, revealing a contact interface between the ectodomains that drives complex formation. Upon binding to CD19, CD81 opens its ectodomain to expose a hydrophobic CD19-binding surface and reorganizes its transmembrane helices to occlude a cholesterol binding pocket present in the apoprotein. Our data reveal the structural basis for CD19-CD81 complex assembly, providing a foundation for rational design of therapies for B cell dysfunction.
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33446559      PMCID: PMC8111558          DOI: 10.1126/science.abd9836

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  54 in total

1.  The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules.

Authors:  L E Bradbury; G S Kansas; S Levy; R L Evans; T F Tedder
Journal:  J Immunol       Date:  1992-11-01       Impact factor: 5.422

2.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

Review 3.  B-cell receptor signaling in the pathogenesis of lymphoid malignancies.

Authors:  Kamil Bojarczuk; Malgorzata Bobrowicz; Michal Dwojak; Nina Miazek; Piotr Zapala; Anders Bunes; Marta Siernicka; Maria Rozanska; Magdalena Winiarska
Journal:  Blood Cells Mol Dis       Date:  2015-07-11       Impact factor: 3.039

4.  The CD19 signal transduction complex of B lymphocytes. Deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu 13.

Authors:  L E Bradbury; V S Goldmacher; T F Tedder
Journal:  J Immunol       Date:  1993-09-15       Impact factor: 5.422

5.  The actin and tetraspanin networks organize receptor nanoclusters to regulate B cell receptor-mediated signaling.

Authors:  Pieta K Mattila; Christoph Feest; David Depoil; Bebhinn Treanor; Beatriz Montaner; Kevin L Otipoby; Robert Carter; Louis B Justement; Andreas Bruckbauer; Facundo D Batista
Journal:  Immunity       Date:  2013-03-14       Impact factor: 31.745

6.  Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus.

Authors:  Rita Kansal; Noah Richardson; Indira Neeli; Saleem Khawaja; Damian Chamberlain; Marium Ghani; Qurat-Ul-Ain Ghani; Louisa Balazs; Sarka Beranova-Giorgianni; Francesco Giorgianni; James N Kochenderfer; Tony Marion; Lorraine M Albritton; Marko Radic
Journal:  Sci Transl Med       Date:  2019-03-06       Impact factor: 17.956

Review 7.  Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors.

Authors:  James N Kochenderfer; Steven A Rosenberg
Journal:  Nat Rev Clin Oncol       Date:  2013-04-02       Impact factor: 66.675

8.  A Phase II Study of Coltuximab Ravtansine (SAR3419) Monotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia.

Authors:  Hagop M Kantarjian; Bruno Lioure; Stella K Kim; Ehab Atallah; Thibaut Leguay; Kevin Kelly; Jean-Pierre Marolleau; Martine Escoffre-Barbe; Xavier G Thomas; Jorge Cortes; Elias Jabbour; Susan O'Brien; Pierre Bories; Corina Oprea; Laurence Hatteville; Hervé Dombret
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2015-12-21

Review 9.  Tetraspanins as regulators of protein trafficking.

Authors:  Fedor Berditchevski; Elena Odintsova
Journal:  Traffic       Date:  2006-12-20       Impact factor: 6.215

10.  CD81 is a novel immunotherapeutic target for B cell lymphoma.

Authors:  Felipe Vences-Catalán; Chiung-Chi Kuo; Ranjani Rajapaksa; Caroline Duault; Noemi Andor; Debra K Czerwinski; Ronald Levy; Shoshana Levy
Journal:  J Exp Med       Date:  2019-05-23       Impact factor: 14.307

View more
  9 in total

1.  Crystal structure of the Tspan15 LEL domain reveals a conserved ADAM10 binding site.

Authors:  Colin H Lipper; Khal-Hentz Gabriel; Tom C M Seegar; Katharina L Dürr; Michael G Tomlinson; Stephen C Blacklow
Journal:  Structure       Date:  2021-11-04       Impact factor: 5.006

2.  Novel CD81 Mutations in a Chinese Patient Led to IgA Nephropathy and Impaired BCR Signaling.

Authors:  Lu Yang; Ping Liu; Hongqiang Du; Ran Chen; Bo Zhou; Yanan Li; Lina Zhou; Xiangli Wang; Cuihua Liu; Yuan Ding; Xuemei Tang; Yongwen Chen; Yunfei An; Xiaodong Zhao
Journal:  J Clin Immunol       Date:  2022-07-18       Impact factor: 8.542

3.  Directed Evolution of Stabilized Monomeric CD19 for Monovalent CAR Interaction Studies and Monitoring of CAR-T Cell Patients.

Authors:  Elisabeth Laurent; Anna Sieber; Benjamin Salzer; Anna Wachernig; Jacqueline Seigner; Manfred Lehner; René Geyeregger; Bernhard Kratzer; Ulrich Jäger; Renate Kunert; Winfried F Pickl; Michael W Traxlmayr
Journal:  ACS Synth Biol       Date:  2021-04-12       Impact factor: 5.249

4.  Acute Csk inhibition hinders B cell activation by constraining the PI3 kinase pathway.

Authors:  Wen Lu; Katarzyna M Skrzypczynska; Arthur Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-26       Impact factor: 11.205

5.  A conserved sequence in the small intracellular loop of tetraspanins forms an M-shaped inter-helix turn.

Authors:  Nikolas Reppert; Thorsten Lang
Journal:  Sci Rep       Date:  2022-03-16       Impact factor: 4.379

6.  A Multiscale Study of Phosphorylcholine Driven Cellular Phenotypic Targeting.

Authors:  Silvia Acosta-Gutiérrez; Diana Matias; Milagros Avila-Olias; Virginia M Gouveia; Edoardo Scarpa; Joe Forth; Claudia Contini; Aroa Duro-Castano; Loris Rizzello; Giuseppe Battaglia
Journal:  ACS Cent Sci       Date:  2022-04-15       Impact factor: 18.728

Review 7.  Regulation of ADAM10 by the TspanC8 Family of Tetraspanins and Their Therapeutic Potential.

Authors:  Neale Harrison; Chek Ziu Koo; Michael G Tomlinson
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

8.  Targeting the tetraspanin CD81 reduces cancer invasion and metastasis.

Authors:  Felipe Vences-Catalán; Ranjani Rajapaksa; Chiung-Chi Kuo; Caitlyn L Miller; Anderson Lee; Vishnu C Ramani; Stefanie S Jeffrey; Ronald Levy; Shoshana Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-15       Impact factor: 11.205

Review 9.  Tetraspanins as Potential Modulators of Glutamatergic Synaptic Function.

Authors:  Amina Becic; Jennifer Leifeld; Javeria Shaukat; Michael Hollmann
Journal:  Front Mol Neurosci       Date:  2022-01-03       Impact factor: 5.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.